A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Autor:	Otto Magnusson, Colin Blackmore, Kang Cai, Jason Swift, Kasthuri Prakash, Daniel Wise, Marilou Wijdicks, Azar Tarakameh, Nikki Carter, Maryam Clausen, Rebecca A. Halpin, Oona Delpuech, Alexander Kohlmann, Mark Fidock, Ruth March, Daniel O'Neill, James Sherwood, Tabetha Sundin
Rok vydání:	2021
Předmět:	0301 basic medicine medicine.medical_specialty Saliva Coronavirus disease 2019 (COVID-19) Science Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Real-Time Polymerase Chain Reaction Asymptomatic Article Essential medicines Specimen Handling 03 medical and health sciences 0302 clinical medicine Nasopharynx Diagnosis Pandemic medicine Humans Intensive care medicine Pandemics Asymptomatic Diseases Multidisciplinary Molecular medicine Diagnostic Tests Routine SARS-CoV-2 business.industry COVID-19 030104 developmental biology COVID-19 Nucleic Acid Testing Workforce RNA Viral Medicine medicine.symptom Infection business 030217 neurology & neurosurgery
Zdroj:	Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021) Scientific Reports
ISSN:	2045-2322
Popis:	Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a246dc36443233b5aa3f8393feb68d65 https://doi.org/10.1038/s41598-021-92070-w Zobrazit plný text záznamu Full text from SpringerLink